The promoters of Hyderabad based biotech firm Jupiter Bioscience Ltd have pledged 13,00,000 equity shares as collateral security against loans from nationalised banks.
In a disclosure to Bombay Stock Exchange, the company clarified that no shares have been pledged by the promoters to secure loan for their own use.
Ranbaxy, India's leading drug maker owns 14.9 per cent stake in Jupiter Bio.
